NCT06322212View on ClinicalTrials.gov

Type 2 Diabetes and Blood Brain Barrier Improvement

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

April 30, 2026

Conditions
Type2diabetes
Interventions
DIETARY_SUPPLEMENT

Thiamine

Participants will be provided instruction to take one 500 mg capsule of Thiamine (Vitamin B1) each day in the morning for 3-months.

OTHER

Placebo

Participants will be provided instruction to take one capsule (placebo) each day in the morning for 3-months.

Trial Locations (1)

90095

RECRUITING

UCLA, Los Angeles

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

University of California, Los Angeles

OTHER